Top Cannabis Investment News, Member Posts, Cannabis Investment Daily Indices and more!

2yrs ago Cannabis harrisbricken Views: 338

In the last two months New York Senator Jeremy Cooney has introduced two pieces of cannabis legislation that could impact New York’s cannabis industry significantly. The first is Senate Bill S7517A, which expands the definition of social and economic equity applicant under the Marijuana Regulation and Taxation Act (MRTA) to include gender equality. The second is Senate Bill S7518 to permit tax deductions for commercial cannabis activities. Let’s go through them both in detail:

S7517A – Expanding the Definition of Social and Economic Equity Applicant

This bill expands the list of qualifying social and economic equity applicants to include “transgender, gender non-conforming and non-binary individuals.” The bill defines “transgender, gender non-conforming and non-binary individuals” as “any person who has a gender identity or expression different from the sex assigned to that individual at birth.”

Senator Cooney has repeatedly spoken about the importance of expanding qualified social and economic applicants to include transgender, gender non-conforming and non-binary individuals. The justification for the legislation explains why:

“Every New Yorker deserves the right to express and identify their gender as they choose. An unintended consequence of [the MRTA] would force certain individuals from choosing between their gender identity and receiving priority for a license. The social equity aspect of the MRTA is meant to uplift historically marginalized groups through economic opportunities in the cannabis industry and this bill furthers that effort.”

S7518 – Permitting Tax Deductions for Commercial Cannabis Activities

The language of this bill is pretty straightforward: the prohibition on deducting expenses in connection with the illegal sale of drugs shall not apply to a licensee under the MRTA. The bill expressly lists each of the license types and incorporates by references the definition of “licensee” under the MRTA. Other cannabis friendly states have passed similar tax deduction laws.

The text of the proposed bill references the underlying Federal tax law upon which the prohibition is (was) based: Section 280E of the Internal Revenue Code. We have written extensively on the subject (e.g. here, here, here, here and here). The short of it is that a cannabis business cannot deduct or credit any amount paid or incurred as part of operating its business, outside of what can be captured in “costs of good sold.”

The impact of S7518 would be significant. By allowing cannabis businesses to deduct their operating expenses at the state level, the legislation would allow them to operate like legitimate business in New York. (Note: this legislation would not change Federal tax law).

The bill’s justification section highlights two of the goals in passing the MRTA: the promotion of social equity and a competitive business environment. As stated in the justification section:

  • “New York cannot realize the goals set in the MRTA for social and economic equity if the cost of doing business prevents the equity candidates from actually participating. . . If [the tax code] goes unchanged, people will be unable or unwilling to leave the legacy market for a licensed business.”
  • The bill will “ensure that adult-use cannabis market will not be dominated solely by large multi-state operators who can afford to pay the higher effective tax rate.”

It is important to note that neither S7517A nor S7518 are law. But the justifications for both pieces of legislation are sound. Stay tuned for further developments in New York cannabis industry, legislative or otherwise!

New York Cannabis Legislation: Expanded Social Equity and Tax Deductions on Harris Bricken.


Today's Cannabis Investment Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.